1. {C}Laurent C, Tchatchueng Mbougua JB, Ngom Gueye NF, Etard JF, Diouf A, Landman R, Molinari N, Girard PM, Sow PS, Ndoye I, Delaporte E.
    Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal
    Trop Med Int Health. (2011);16(2):217-222.

 

  1. {C}Laurent C, Kouanfack C, Laborde-Balen G, Aghokeng AF, Mbougua JB, Boyer S, Carrieri MP, Mben JM, Dontsop M, Kazé S, Molinari N, Bourgeois A, Mpoudi-Ngolé E, Spire B, Koulla-Shiro S, Delaporte E; Stratall ANRS 12110/ESTHER study group.

Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.

Lancet Infect Dis. 2011 Nov;11(11):825-33. doi: 10.1016/S1473-3099(11)70168-2. Epub 2011 Aug 8.

 

  1. Kfutwah AK, Tejiokem MC, Ateba FN, Ndongo JA, Penda IC, Ngoupo PA, Tchendjou P, Chewa G, Boisier P, Rouzioux C, Warszawski J, Faye A; ANRS 12140-Pediacam Study Group. Seronegativation in early treated HIV-infected infants: frequency and potential implications on care and follow-up in a resource-limited country.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e43-6. doi: 10.1097/QAI.0b013e31822d49f0.

 

  1. Harvala H, Sharp CP, Ngole EM, Delaporte E, Peeters M, and Simmonds P
    Detection and Genetic Characterization of Enteroviruses Circulating among Wild Populations of Chimpanzees in Cameroon: Relationship with Human and Simian Enteroviruses.
    J Virol (2011); 85(9):4480-6.

 

  1. Boyer S, Abu-Zaineh M, Blanche J, Loubière S, Bonono RC, Moatti JP, Ventelou B.

Does HIV services decentralization protect against the risk of catastrophic health expenditures?: some lessons from Cameroon.

Health Serv Res. 2011 Dec;46(6pt2):2029-56. doi: 10.1111/j.1475-6773.2011.01312.x. Epub 2011 Sep 26.

 

  1. Aghokeng AF, Kouanfack C, Laurent C, Ebong E, Atem-Tambe A, Butel C, Montavon C, Mpoudi-Ngole E, Delaporte E, Peeters M.

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.

AIDS. 2011 Nov 13;25(17):2183-8. doi: 10.1097/QAD.0b013e32834bbbe9

 

  1. Aghokeng AF, Mpoudi-Ngole E, Chia JE, Edoul EM, Delaporte E, Peeters M.

High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity.

J Clin Microbiol. 2011 Apr;49(4):1635-41. doi: 10.1128/JCM.01478-10.

 

  1. D’ALMEIDA C, ESSI, MJ, CAMARA M, CORIAT B,

Access to Second-Line Antiretroviral Therapeutic Regimens in Low-Resource Settings: Experiences from Cameroon JAIDS. Journal of Acquired Immune Deficiency Syndromes. 57():S55-S58, July 1, 2011. Doi 10.1097/QAI.0b013e318220787d

 

  1. BOYER S, KOULA-SHIRO S, ABE C, SPIRE B and MOATTI JP.

Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experience.

Current Opinion in HIV and AIDS. July 2011;6 (4): 239-244

 

  1. {C}BOYER S, ABU-ZAINEH M., BLANCHE J, LOUBIERE S, BONONO R.C., MOATTI JP, VENTELOU B.

Does HIV-services decentralization protect against the risk of catastrophic health expenditures? Some lessons from Cameroon.

Health Services Research, 2011 Dec; 46(6pt2): 2029-56. Doi 10.1111/j. 1475-6773.2011.01312.x.

 

  1. BOYER S., PROTOPOPESCU C., MARCELLIN F., CARRIERI M-P., KOULLA-SHIRO S., MOATTI J-P., SPIRE B. and the EVAL study group,

Performance of HIV care decentralization from the patient’s perspective: health-related quality of life and perceived quality of services in Cameroon.

Health Policy and Planning. 2011, 1-15

 

  1. BOYER S., CLERC, I., BONONO R. C., MARCELLIN F., BILÉ P. C. & VENTELOU B.

Non-Adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors.

Social Science & Medicine, 2011, 72(8) : 1383-92

 

  1. {C}EBOKO F, « Soigner le sida en Afrique. Recherche biomédicale et engagement humanitaire »,

Ethnologie française, 2011/3 Vol. 41, p. 497-507. DOI : 10.3917/ethn.113.0497

 

  1. KOUANFACK C, AGHOKENG AF, MONDAIN AM, BOURGEOIS A, KENFACK A, MPOUDI-NGOLÉ E, DUCOS J, DELAPORTE E, LAURENT C.

Lamivudine-resistant hepatitis B virus infection in HIV+ patients receiving antiretroviral therapy in a public routine clinic in Cameroon.

Antivir Ther 2012, 17(2):321-6. doi: 10.3851/IMP1911.

 

  1. KFTUWAH A, TEJIOKEM M, ATEBA F et al, Seronegativation in early treated HIV-infected infants: Frequency and potential implications on care and follow-up in a resource-limited country,

J Acquir Immune Defic Syndr _ Volume 58, Number 2, October 1, 2011

 

  1. LAURENT C. Scaling up HIV treatment in resource-limited countries: The challenge of staff shortages.

J Public Health Policy 2011, 32(2): 211-8.

 

  1. LAURENT C, KOUANFACK C, LABORDE-BALEN G, AGHOKENG AF, TCHATCHUENG MBOUGUA JB, BOYER S, CARRIERI MP, MBEN JM, DONTSOP M, KAZÉ S, MOLINARI N, BOURGEOIS A, MPOUDI-NGOLÉ E, SPIRE B, KOULLA-SHIRO S, DELAPORTE E. HIV viral load, CD4 cell count and clinical monitoring versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.

Lancet Infect Dis 2011, published online Aug 9. DOI:10.1016/1473-3099(11)70168-2.

 

  1. RASSON S., BOYER S., FUGON L., PROTOPOPESCU C., MARCELLIN F., KOULLA-SHIRO S., KOUANFACK C., SPIRE B., MOATTI JP, CARRIERI MP. and the EVAL Study Group. Decentralization of access to antiretroviral therapy in Cameroon: Correlates of HIV physicians’ knowledge in HIV care.

Antiviral Therapy, 2011, 16(3): 423-428.

 

  1. ROUX P., KOUANFACK C., COHEN J., MARCELLIN F., BOYER S., DELAPORTE E., CARRIERI M.P, LAURENT C., SPIRE B., and the Stratall ANRS 12110/ESTHER Study Group.  Adherence to antiretroviral treatment in HIV positive patients in the Cameroon context: promoting the use of medication reminder methods.

J Acquir Immune Defic Syndr 2011, 57(Suppl 1): S40-3.

 

  1. SUZAN-MONTI M, BLANCHE J, BILE P, KOULLA-SHIRO S, ABU-ZAINEH, M, MARCELLIN F, BOYER S, CARRIERI MP, SPIRE B. Individual and structural factors associated with HIV status disclosure to main partner  in Cameroon: ANRS 12-116 EVAL survey, 2006-2007. JAIDS,

Journal of Acquired Immune Deficiency Syndromes. 57():S22-S26, July 1, 2011.

 

  1. TEJIOKEM MC, FAYE A, PENDA IC, GUEMKAM G, ATEBA NDONGO F, CHEWA G, REKACEWICZ C, ROUSSET D, KFUTWAH A, BOISIER P, WARSZAWSKI J; ARNS 12140-PEDIACAM study group. Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon.

PLoS One. 2011;6(7):e21840. Epub 2011 Jul 19.

 

  1. TCHENDJOU P, KOKI P, EBOKO F, MALATESTE K, NGO ESSOUNGA A, AMASSANA D, MOSSUS T, TEJIOKEM M, BOISIER P et ORNE GLIEMAN J, Factors Associated With History of HIV Testing Among Pregnant Women and Their Partners in Cameroon: Baseline Data From a Behavioral Intervention Trial (ANRS 12127 Prenahtest).

J Acquir Immune Defic Syndr 2011;57:S9–S15)